Clinical Trials Directory

Trials / Sponsors / UCB Pharma

UCB Pharma

Industry · 242 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Br
Healthy Volunteers
Phase 12015-11-01
CompletedA Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients
Epilepsy
Phase 22014-02-13
CompletedStudy to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset
Epilepsy
Phase 32013-08-29
CompletedStudy to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriat
Psoriasis
Phase 12013-08-01
CompletedSafety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
Immune System Diseases, Autoimmune Diseases, Lupus Erythematosus, Systemic
Phase 12013-01-01
CompletedStudy to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Ch
Healthy
Phase 12012-08-01
CompletedRotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease P
Idiopathic Parkinson's Disease
Phase 32012-07-01
CompletedRotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's
IDIOPATHIC PARKINSON'S DISEASE
Phase 32012-07-01
CompletedCrossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Sub
Healthy
Phase 12012-05-01
CompletedA Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes
Human Volunteers
Phase 12012-05-01
CompletedAn Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dos
Human Volunteers
Phase 12012-05-01
CompletedRotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs
Restless Legs Syndrome
Phase 32012-03-01
CompletedBioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subje
Healthy Volunteers
Phase 12012-03-01
CompletedA Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects
Healthy Subjects
Phase 12012-01-01
CompletedA Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Cert
Rheumatoid Arthritis
Phase 32012-01-01
CompletedOpen Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects
Systemic Lupus Erythematosus
Phase 22012-01-01
CompletedEffect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males
Healthy Volunteers
Phase 12012-01-01
TerminatedEffect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuati
Advanced Parkinson's Disease
Phase 32012-01-01
CompletedeValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Epilepsy
Phase 32011-12-01
CompletedPharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients
Healthy Subjects, Renal Impairments
Phase 42011-11-01
CompletedStudy Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 1 / Phase 22011-10-01
CompletedNon-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Dis
Parkinson's Disease
2011-09-01
CompletedSafety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
Epilepsy
Phase 32011-08-01
TerminatedCertolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD
Rheumatoid Arthritis, Crohn's Disease
2011-08-01
CompletedOpen Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 32011-07-01
CompletedLong Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patie
Arthritis,Rheumatoid
2011-07-01
CompletedOpen-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Epilepsy
Phase 22011-07-01
TerminatedHormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide
Epilepsy, Partial
Phase 32011-07-01
CompletedEffect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
Restless Legs Syndrome
2011-07-01
CompletedBioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects
Healthy Volunteers
Phase 12011-06-01
CompletedAn Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizur
Epilepsy, Generalized Tonic-clonic Seizures
Phase 32011-06-01
CompletedStudy to Compare Adhesiveness of Two Different Rotigotine Patch Formulations
Parkinson's Disease
Phase 12011-04-01
CompletedThree-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chine
Healthy Volunteers
Phase 12011-03-01
CompletedCaregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregive
Idiopathic Parkinson's Disease
2011-03-01
CompletedPlacebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-moto
Idiopathic Parkinson's Disease
Phase 42011-02-01
TerminatedA 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arth
Rheumatoid Arthritis
Phase 32011-02-01
CompletedObservational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution
Epilepsy
2011-01-01
CompletedBrivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
Epilepsy
Phase 32010-12-01
CompletedStudy of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 32010-12-01
CompletedStudy of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (
Systemic Lupus Erythematosus
Phase 32010-12-01
CompletedMagnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arth
Rheumatoid Arthritis
Phase 32010-12-01
CompletedEfficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tum
Rheumatoid Arthritis
Phase 22010-11-01
CompletedPharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male
Healthy Volunteers
Phase 12010-11-01
CompletedA Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subject
Rheumatoid Arthritis
Phase 42010-11-01
CompletedBelgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizure
Seizures
2010-09-01
CompletedExtension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certoliz
Crohn's Disease
Phase 22010-08-01
CompletedTrial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure
Partial Epilepsies
Phase 42010-06-01
CompletedNon-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
Idiopathic Restless Legs Syndrome
2010-05-01
CompletedEvaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male Volunteers
Sperm Quality
Phase 12010-03-01
CompletedSafety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
Immune System Diseases, Autoimmune Diseases, Lupus Erythematosus, Systemic
Phase 12010-03-01
CompletedStudy in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent
Healthy Volunteers
Phase 12010-01-01
CompletedA Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With
Epilepsy
Phase 22009-11-01
CompletedTo Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis U
Arthritis, Rheumatoid Arthritis
Phase 1 / Phase 22009-10-01
CompletedHuman Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)
Healthy
Phase 12009-09-01
CompletedNational Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treate
Rheumatoid Arthritis
2009-09-01
CompletedAssessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response W
Rheumatoid Arthritis
Phase 42009-09-01
CompletedTrial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Se
Partial Epilepsies
Phase 42009-08-01
CompletedStudy in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Eq
Healthy Volunteers
Phase 12009-07-01
CompletedFollow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
Rheumatoid Arthritis
Phase 32009-01-01
CompletedAn Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Br
Epilepsy
Phase 32008-11-01
CompletedTo Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Sub
Epilepsy
Phase 12008-11-01
CompletedNamed Patient Program With Rotigotine Transdermal System
Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
2008-11-01
CompletedPost-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onse
Epilepsies, Partial
2008-10-01
CompletedStudy in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver
Healthy
Phase 12008-10-01
CompletedThe First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males
Pharmacokinetics
Phase 12008-09-01
CompletedOpen Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthrit
Rheumatoid Arthritis
Phase 32008-09-01
TerminatedA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam
Epilepsy
Phase 32008-08-01
TerminatedA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam
Epilepsy
Phase 32008-08-01
CompletedClinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Br
Epilepsy
Phase 12008-07-01
CompletedCertolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 32008-07-01
CompletedCDP323 Biomarker Study
Relapsing Multiple Sclerosis
Phase 1 / Phase 22008-07-01
CompletedRheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
Rheumatoid Arthritis
Phase 32008-06-01
WithdrawnA Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Se
Epilepsies, Partial
Phase 2 / Phase 32008-05-01
WithdrawnOpen Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy
Epilepsy
Phase 32008-05-01
CompletedOpen-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Di
Systemic Lupus Erythematosus
Phase 22008-05-01
CompletedA Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With
Seasonal Allergic Rhinitis
Phase 42008-04-01
CompletedStudy to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn'
Crohn Disease
Phase 32008-03-01
CompletedSafety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
Allergic Rhinitis, Chronic Urticaria
Phase 32008-03-01
CompletedSafety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years
Allergic Rhinitis, Chronic Urticaria
Phase 32008-03-01
CompletedA Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With
Seasonal Allergic Rhinitis
Phase 42008-03-01
CompletedBio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy Volunteers
Bioavailability Study on Healthy Volunteers
Phase 12008-02-01
CompletedTrial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therap
Epilepsy
Phase 32008-02-01
CompletedNaturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Ki
Epilepsy
2008-02-01
CompletedStudy of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease
Systemic Lupus Erythematosus
Phase 22008-01-01
CompletedDosing Flexibility Study in Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 42007-12-01
CompletedLong Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures
Epilepsy
Phase 32007-12-01
WithdrawnA Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
Crohn's Disease
Phase 32007-11-01
CompletedComparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)
Healthy
Phase 12007-10-01
CompletedA Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery
Parkinson's Disease
Phase 42007-09-01
CompletedDouble-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset
Epilepsy
Phase 32007-09-01
CompletedOpen-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Epilepsy
Phase 22007-09-01
CompletedEvaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study
Rhinitis Allergic, Persistent
2007-09-01
CompletedConversion to Monotherapy Study With Keppra XR for Partial Seizures
Epilepsy
Phase 32007-08-01
CompletedSafety and Tolerability Trial of Switching From Ropinirole to Rotigotine
Parkinson's Disease
Phase 32007-07-01
CompletedTrial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Parkinson's Disease
Phase 32007-07-01
TerminatedLong-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects Wit
Parkinson's Disease
Phase 32007-07-01
TerminatedPlacebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effec
Multiple Sclerosis
Phase 22007-05-01
CompletedRandomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Parkinson's Disease
Phase 32007-05-01
TerminatedCertolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed In
Crohn's Disease
Phase 32007-04-01
CompletedAdverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patie
Epilepsy
2007-04-01
TerminatedTrial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee
Osteoarthritis
Phase 22007-03-01
CompletedEvaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Allergies
2007-03-01
CompletedEfficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and
Epilepsy
2007-03-01
CompletedThe Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
Fibromyalgia Syndrome
Phase 22007-03-01
CompletedA Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophy
Migraine
Phase 22007-02-01
CompletedExamining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's D
Crohn's Disease
Phase 32007-01-01
WithdrawnEvaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
Crohn Disease
Phase 32007-01-01
WithdrawnStudy of Epratuzumab in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 32007-01-01
CompletedTrial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
Parkinson's Disease
Phase 12006-12-01
TerminatedCorticosteroid Sparing Effect of Certolizumab in Crohn's Disease
Crohn's Disease
Phase 32006-11-01
CompletedBrivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults
Unverricht-Lundborg Disease
Phase 32006-11-01
CompletedAssessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia
Fibromyalgia Syndrome
Phase 22006-10-01
CompletedFollow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's
Crohn's Disease
Phase 32006-10-01
CompletedA Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR
Epilepsy
Phase 32006-08-01
CompletedEfficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms
Restless Legs Syndrome
Phase 22006-08-01
CompletedCompare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Expose
Rhinitis, Allergic, Seasonal
Phase 32006-07-01
TerminatedAlprostadil in Maculopathy Study (AIMS)
Macular Degeneration
Phase 32006-07-01
CompletedA Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy
Painful Diabetic Neuropathy
Phase 32006-06-30
CompletedTransdermal Rotigotine User Surveillance Study
Idiopathic Parkinson Disease
2006-06-01
CompletedFollow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming Fro
Epilepsy
Phase 32006-06-01
CompletedStudy of Epratuzumab in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 22006-06-01
CompletedObservational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyre
Narcolepsy
2006-05-01
CompletedMaintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C870
Crohn's Disease
Phase 22006-05-01
CompletedEfficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis
Psoriasis
Phase 22006-04-01
CompletedCross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
Epilepsy
2006-04-01
CompletedCertolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab
Crohn's Disease
Phase 32006-04-01
CompletedClinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease
Crohn's Disease
Phase 22006-03-02
CompletedQuality of Life and Adverse Effects in Epilepsy Patients (EPIKA)
Epilepsy
2006-03-01
WithdrawnOpen Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Tr
Epilepsy
Phase 32006-02-01
CompletedMucosal Healing Study in Crohn's Disease (CD)
Crohn's Disease
Phase 32006-02-01
CompletedEfficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms
Parkinson's Disease
Phase 22006-02-01
CompletedPhase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
Idiopathic Restless Legs Syndrome
Phase 32006-01-01
CompletedCardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Diseas
Parkinson's Disease
Phase 12006-01-01
CompletedA Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhiniti
Rhinitis, Allergic, Seasonal
Phase 22006-01-01
CompletedAn Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs
Restless Legs Syndrome
Phase 32005-12-01
CompletedCUTE (Chronic Urticaria Treatment Evaluation)
Chronic Idiopathic Urticaria
Phase 42005-12-01
CompletedA Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
Epilepsy
Phase 22005-11-07
CompletedA Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic
Restless Legs Syndrome
Phase 32005-11-01
CompletedA Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of
Rheumatoid Arthritis
Phase 32005-11-01
CompletedEfficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/
Chronic Plaque Psoriasis
Phase 22005-10-01
CompletedTrial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSR
Generalized Anxiety Disorder, Panic Disorder
Phase 42005-10-01
CompletedRandomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizi
Dermatitis, Eczema
Phase 32005-10-01
CompletedFollow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Epilepsy
Phase 32005-09-01
CompletedA Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer
Carcinoma, Non-Squamous Non-Small-Cell Lung Cancer
Phase 22005-08-15
CompletedA Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ Wit
Parkinson's Disease
Phase 32005-06-01
CompletedA Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Sympto
Rheumatoid Arthritis
Phase 32005-06-01
CompletedA Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Sy
Rheumatoid Arthritis
Phase 32005-06-01
CompletedA Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Adm
Diabetic Gastroparesis
N/A2005-06-01
TerminatedStudy of Epratuzumab in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 32005-06-01
CompletedPOPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)
Seasonal Allergic Rhinitis
Phase 42005-05-01
TerminatedStudy of Epratuzumab in Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 32005-05-01
CompletedLevetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
Dyskinesia, Medication-induced
Phase 22005-05-01
CompletedThree Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome
Restless Legs Syndrome
Phase 32005-05-01
CompletedFour Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
Restless Legs Syndrome
Phase 32005-05-01
CompletedA Study of Brivaracetam in Subjects With Partial Onset Seizures
Epilepsy, Focal
Phase 22005-05-01
CompletedLEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)
Rhinitis, Allergic, Perennial
Phase 42005-04-01
CompletedAn Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15
Epilepsy
Phase 12005-04-01
TerminatedPharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
Lupus Erythematosus, Systemic
Phase 22005-04-01
CompletedSafety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizur
Epilepsies, Partial
Phase 2 / Phase 32005-02-01
CompletedA Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid
Rheumatoid Arthritis
Phase 32005-02-01
CompletedAn Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Su
Idiopathic Parkinson's Disease
Phase 32005-02-01
CompletedLevetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patient
Epilepsy
Phase 32005-02-01
CompletedA Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Con
Multiple Sclerosis
Phase 32005-01-01
CompletedA Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy
Painful Diabetic Neuropathy
Phase 32004-12-21
CompletedA Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System I
Parkinson's Disease
Phase 32004-12-01
CompletedA Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Di
IDIOPATHIC PARKINSON'S DISEASE
Phase 32004-12-01
CompletedUCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
Birth Defects, Pregnancy Complications, Epilepsy
2004-12-01
CompletedAssess Safety and Efficacy of Lacosamide in Patients With Partial Seizures
Epilepsy
Phase 32004-12-01
CompletedWheal and Flare Reaction During 24 Hours in Allergic Volunteers.
Allergy
Phase 12004-11-01
CompletedA Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor I
Parkinson's Disease
Phase 32004-11-01
CompletedA Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neur
Neuralgia, Postherpetic
Phase 22004-10-11
CompletedLong-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures
Epilepsy, Partial
Phase 32004-10-01
CompletedTrial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal D
Diabetic Neuropathies
Phase 32004-10-01
CompletedA Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
Epilepsy, Partial
Phase 32004-10-01
CompletedA Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy
Diabetic Neuropathy
Phase 2 / Phase 32004-09-01
CompletedA 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
Epilepsy, Partial
Phase 22004-09-01
CompletedAn Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Park
Advanced Stage Parkinson's Disease
Phase 32004-08-01
CompletedA Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disin
ANXIETY
Phase 32004-08-01
CompletedDouble-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
Epilepsy, Partial
Phase 32004-07-01
CompletedFacial Thermography Study of Levocetirizine Versus Cetirizine
Anti-allergic Agents
Phase 42004-07-01
TerminatedPrevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic
Asthma
Phase 32004-06-01
CompletedSafety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Ons
Epilepsy
Phase 22004-06-01
CompletedOpen Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rh
Allergic Rhinitis
Phase 22004-06-01
CompletedA Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy
Partial Seizures With or Without Secondary Generalization
Phase 32004-05-01
CompletedTesting the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Wei
Hypertension
N/A2004-05-01
CompletedStudy Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropat
Painful Diabetic Neuropathy
Phase 32004-05-01
CompletedA 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)
Neuralgia, Postherpetic
Phase 22004-04-01
CompletedEfficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensit
Rhinitis, Allergic, Seasonal
Phase 32004-04-01
CompletedA Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy
Diabetic Neuropathy
Phase 2 / Phase 32004-04-01
CompletedA Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927
Epilepsy
Phase 22004-03-04
CompletedRotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled o
Parkinson Disease, Idiopathic
Phase 32004-03-01
CompletedOpen Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
Epilepsy, Partial
Phase 32004-03-01
CompletedSPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Seco
Epilepsy
Phase 32004-03-01
CompletedStudy to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Du
Crohn's Disease
Phase 32004-02-01
CompletedEfficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects
Rhinitis, Allergic, Seasonal
N/A2004-02-01
CompletedA Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrat
Parkinson's Disease
Phase 32004-01-01
CompletedA Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a
Crohn's Disease
Phase 32003-12-01
CompletedA Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neu
Diabetic Neuropathy
Phase 32003-12-01
CompletedOpen Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
Epilepsy, Partial
Phase 42003-11-24
CompletedStudy to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (General
Anxiety Disorders
Phase 22003-09-01
CompletedEfficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis
Rhinitis, Allergic, Perennial
Phase 32003-09-01
CompletedTo Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhi
Rhinitis, Allergic, Seasonal
Phase 32003-08-01
CompletedStudy to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticari
Urticaria
Phase 32003-08-01
CompletedLevetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias
Idiopathic Parkinson Disease
Phase 22003-07-01
CompletedMonotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
Epilepsy, Tonic-clonic
Phase 32003-07-01
CompletedLong-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)
Restless Legs Syndrome
Phase 22003-07-01
CompletedEfficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthriti
Rheumatoid Arthritis
Phase 32003-06-01
CompletedRotigotine Restless Legs Syndrome Dose Finding Trial
Idiopathic Restless Leg Syndrome
Phase 22003-04-01
CompletedTrial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial
Epilepsy
Phase 42003-03-01
CompletedA Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Ep
Epilepsy
Phase 42003-03-01
CompletedOpen Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 32003-03-01
CompletedDetermine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
Epilepsy, Partial
Phase 42003-03-01
CompletedStudy on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenia
Epilepsy
Phase 42002-11-01
CompletedAn Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Pos
Postherpetic Neuralgia
Phase 22002-11-01
CompletedEfficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arth
Arthritis, Rheumatoid
Phase 32002-10-01
CompletedPharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Tha
Epilepsy
Phase 22002-09-01
CompletedEffect of Brivaracetam in Photosensitive Epileptic Subjects
Epilepsy
Phase 22002-09-01
CompletedEfficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
Rhinitis, Allergic, Seasonal
Phase 42002-09-01
CompletedEvaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust
Rhinitis, Allergic, Perennial
Phase 42002-09-01
CompletedEfficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhini
Rhinitis, Allergic, Perennial
Phase 32002-08-01
CompletedAn Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parki
Parkinson's Disease
Phase 32002-08-01
CompletedAn Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkins
Early Stage Parkinson's Disease
Phase 32002-08-01
CompletedAn Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkins
Early-Stage Parkinson's Disease
Phase 32002-06-01
CompletedMonotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy
Generalized Epilepsy
Phase 32002-06-01
CompletedThe COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting
Attention Deficit Hyperactivity Disorder
Phase 42002-05-01
CompletedAn Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Dia
Painful Diabetic Neuropathy
Phase 22002-04-01
CompletedA Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and T
Postherpetic Neuralgia
Phase 22002-02-01
CompletedPharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
Epilepsy, Partial
Phase 42002-01-01
CompletedEfficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms
Cough
Phase 22001-12-01
CompletedLevetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults
Generalized Convulsive Epilepsy
Phase 32001-11-01
CompletedStudy to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized E
Generalized Convulsive Epilepsy
Phase 32001-09-01
CompletedTo Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
Partial Epilepsies
Phase 22001-08-01
CompletedA Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy
Painful Diabetic Neuropathy
Phase 22001-06-01
CompletedAn Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide
Chronic Refractory Neuropathic Pain
Phase 22001-05-01
CompletedProstaglandin E1 in Outpatients With Intermittent Claudication
Stage II Peripheral Arterial Occlusive Disease, Intermittent Claudication Fontaine Stage II PAOD
Phase 32001-04-01
CompletedBridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
Epilepsy
Phase 22001-01-01
CompletedStudy to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestina
Peptic Ulcer
Phase 22000-09-01
CompletedS.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Epilepsy
Phase 42000-08-01
CompletedA Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence S
Absence Seizures
Phase 22000-05-01
CompletedEfficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI
Memory Disorders
N/A2000-05-01
CompletedEfficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onse
Epilepsy
Phase 31999-09-01
CompletedA Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
Epilepsy, Partial
Phase 31998-01-26